ENFENAMIC ACID
CAS No. 23049-93-6
ENFENAMIC ACID( —— )
Catalog No. M22221 CAS No. 23049-93-6
Enfenamic acid is a platelet aggregation inhibitor and with antirheumatic.Dose-matched comparison between zinc-salt of enfenamic acid and the parent compound was carried out in experimentally wounded male albino rats bearing either sutured incision, dead-space or excision wounds.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 178 | In Stock |
|
| 5MG | 267 | In Stock |
|
| 10MG | 408 | In Stock |
|
| 25MG | 672 | In Stock |
|
| 50MG | 945 | In Stock |
|
| 100MG | 1278 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameENFENAMIC ACID
-
NoteResearch use only, not for human use.
-
Brief DescriptionEnfenamic acid is a platelet aggregation inhibitor and with antirheumatic.Dose-matched comparison between zinc-salt of enfenamic acid and the parent compound was carried out in experimentally wounded male albino rats bearing either sutured incision, dead-space or excision wounds.
-
DescriptionEnfenamic acid is a platelet aggregation inhibitor and with antirheumatic.Dose-matched comparison between zinc-salt of enfenamic acid and the parent compound was carried out in experimentally wounded male albino rats bearing either sutured incision, dead-space or excision wounds. Result showed that enfenamic-acid significantly decreased breaking-strength of incision wounds and this effects was totally reversed by zinc present in enfenamic acid-zinc salt. Both the parent compound and the salt had significant granulation suppressant effect in dead-space wounds. In excision wounds epithelization was enhanced by enfenamic acid only. The wound contraction was not affected by either test compound.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetPlatelet aggregation
-
Recptorplatelet aggregation
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number23049-93-6
-
Formula Weight241.29
-
Molecular FormulaC15H15NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESc1(c(NCCc2ccccc2)cccc1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Rao C M , Kumar A , Kulkarni D R . Effects of enfenamic acid and its zinc salt on wound-healing.[J]. Indian journal of physiology and pharmacology, 1988, 32(1):61-66.
molnova catalog
related products
-
Suloctidil
Suloctidil is a new drug that is currently being evaluated in many clinical trials for use in dementia and thrombotic disorders.
-
SDZ-62-434
SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.
-
Mutant EGFR inhibito...
Mutant EGFR inhibitor is a selective and potent Mutated EGFR inhibitor, inhibits L858R activating mutant, the Exonl9 deletion activating mutant and the T790M resistance mutant.
Cart
sales@molnova.com